December 9, 2008, Mr. Jack Kerins, Chief Executive Officer of Sun Biomedical Laboratories, Inc of U.S.A., and Mr. Jim Hallam, Chairman of Turnberry Funds Management of Austrilia paid a three-day visitto Shanghai Siyi Biotechnology Co. Ltd. During the three days, SBL, Turnberry and Siyi have respectively made revision and summary of their achievement in 2008. SBL and Turnberry both expressed their appreciation to the great progress of Saliva Drug Screen Device cooperation project. Meanwhile, Siyi showed great thankfulness for support and help from SBL and Turnberry since this project started. Furthermore, the three parties have discussed about the project cooperation of 2009, respectively expressingopinions on the adjustment of product configuration of the current 4-in-1 test device and the incoming 8-in-1 test device. In addition, they have also made thorough research and discussion regarding the prospect of drug prevention market in China and in the whole world, clarifying scope of marketing. All of the three parties have expressed great sincerity and confidence in their project cooperation. And, they’ve also put forward constructive suggestions and strategic proposals to perfect this cooperation. Finally, in a warm and friendly atmosphere, the three parties signed the memorandum
